Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2

Conditions

Breast Neoplasms 33Neoplasms 16Prostatic Neoplasms 15Lung Neoplasms 11Carcinoma, Hepatocellular 11Multiple Myeloma 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Papillomavirus Infections 6Pain, Postoperative 6Neoplasm Metastasis 6Liver Neoplasms 6Leukemia, Myeloid, Acute 6Stomach Neoplasms 5Recurrence 5Lymphoma, Non-Hodgkin 4Kidney Neoplasms 4Heart Failure 4Glioma 4Febrile Neutropenia 4Carcinoma, Renal Cell 4Brain Neoplasms 4Warts 3Vomiting 3Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Skin Neoplasms 3Rectal Neoplasms 3Pituitary Neoplasms 3

Interventions

naldemedine 1Polyethylene Glycols 1Magnesium Hydroxide 1Electrolytes 1Dosage Forms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Opioid-Induced Constipation × Clear all
NCT07038551 2025-07-02

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

International University of Health and Welfare

Phase 4 Recruiting
120 enrolled
Other

Opioid-Induced Constipation, Constipation, Nausea, Vomiting

NCT05216328 2024-11-22

OMAMA

Amsterdam UMC, location VUmc

Phase 4 Recruiting
330 enrolled
Other

Cancer Pain, Opioid-Induced Constipation, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡